Ratnakar Lavu, Executive Vice President and Chief Digital Information Officer of Elevance Health, Inc. (NYSE:ELV), filed a Form 4 on November 6, 2026, disclosing the sale of 1,300 shares of common stock on November 5, 2026.
Michael Manning Collier, Executive Vice President at HealthStream Inc, filed a Form 4 on November 6, 2026, reporting transactions in HealthStream common stock and employee stock options dated November 5, 2026.
Boston Scientific Corp Chairman, President and CEO Michael F. Mahoney filed a Form 4 on November 6, 2026, disclosing two gift transactions dated November 4, 2026, involving the transfer of Boston Scientific common stock through two irrevocable trusts.
Scott Alexander Roberts, CFO and SVP of HealthStream Inc, filed a Form 4 on November 6, 2026, disclosing the sale of 9,500 shares of common stock on November 5, 2026.
Director Deborah Taylor Tate filed a Form 4 with the SEC on November 6, 2026, reporting the sale of 3,281 shares of HealthStream Inc. common stock on November 5, 2026.
Kevin P. O'Hara, Executive Vice President of HealthStream Inc, filed a Form 4 on November 6, 2026, disclosing the sale of 4,000 shares of common stock on November 5, 2026.
Boris F. Shimanovsky, EVP and Chief Technology Officer of ZipRecruiter, Inc., filed a Form 4 on November 6, 2026, disclosing the sale of 30,000 shares of Class A Common Stock on November 4, 2026.
Lesley Goldwasser filed an initial statement of beneficial ownership with the SEC on November 6, 2026, disclosing her status as a newly appointed director of The Travelers Companies, Inc., with a triggering event date of November 4, 2026.
Editas Medicine, Inc. CEO and Director Gilmore O'Neill filed a Form 4 on November 6, 2026, disclosing the acquisition of 43,567 shares of common stock on November 5, 2026, through the vesting of a performance-based restricted stock unit award tied to the achievement of …
Staci M. Woolsey, Chief Financial Officer of Granite Construction Inc, filed a Form 4 on November 6, 2026, disclosing a tax-withholding transaction on November 5, 2026, in which 188 shares of common stock were surrendered at $121 per share upon vesting.